An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations
- 27 March 2007
- journal article
- case report
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (13), 5443-5448
- https://doi.org/10.1073/pnas.0701290104
Abstract
The seven-spanning calcium-sensing receptor (CaSR) activates multiple G proteins including Gq and Gi, and thereby activates a variety of second messengers and inhibits parathyroid hormone (PTH) secretion. However, the exact signaling mechanisms underlying the functional activity of CaSR are not yet fully understood. The heterozygous inactivation of CaSR or its inhibition by antibody blocking results in either familial hypocalciuric hypercalcemia or acquired hypocalciuric hypercalcemia (AHH), respectively. Here, we report the identification of a unique CaSR autoantibody in an AHH patient. Paradoxically, we find that this autoantibody potentiates the Ca(2+)/Gq-dependent accumulation of inositol phosphates by slightly shifting the dose dependence curve of the Ca(2+) mediated activation of phosphatidylinositol turnover to the left, whereas it inhibits the Ca(2+)/Gi-dependent phosphorylation of ERK1/2 in HEK293 cells stably expressing human CaSR. Treatment of these same cells with a calcimimetic, NPS-R-568, augments the CaSR response to Ca(2+), increasing phosphatidylinositol turnover and ERK1/2 phosphorylation, and overcoming the autoantibody effects. Our observations thus indicate that a calcium-stimulated CaSR primed by a specific autoantibody adopts a unique conformation that activates Gq but not Gi. Our findings also suggest that CaSR signaling may act via both Gq and Gi to inhibit PTH secretion. This is the first report of a disease-related autoantibody that functions as an allosteric modulator and maintains G protein-coupled receptors (GPCRs) in a unique active conformation with its agonist. We thus speculate that physiological modulators may exist that enable an agonist to specifically activate only one signaling pathway via a GPCR that activates multiple signaling pathways.Keywords
This publication has 45 references indexed in Scilit:
- G protein‐coupled receptors: a count of 1001 conformationsFundamental & Clinical Pharmacology, 2005
- Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin IINature, 2004
- Seven-transmembrane receptorsNature Reviews Molecular Cell Biology, 2002
- Mitogen-Activated Protein Kinase Cascade in Human Normal and Tumoral Parathyroid CellsJournal of Clinical Endocrinology & Metabolism, 2002
- Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled ReceptorsEndocrine Reviews, 2000
- Selective Regulation of Gαq/11 by an RGS Domain in the G Protein-coupled Receptor Kinase, GRK2Published by Elsevier BV ,1999
- Mutations in G proteins and G protein-coupled receptors in endocrine diseaseJournal of Clinical Endocrinology & Metabolism, 1996
- Agonist-receptor efficacy II: agonist trafficking of receptor signalsTrends in Pharmacological Sciences, 1995
- Rapid GDP release from Gsα in patients with gain and loss of endocrine functionNature, 1994
- Control of PTH secretion is mediated through calcium channels and is blocked by pertussis toxin treatment of parathyroid cellsBiochemical and Biophysical Research Communications, 1986